We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+12.78%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$506M
AUM Growth
-$51.4M
Cap. Flow
-$43.2M
Cap. Flow %
-8.54%
Top 10 Hldgs %
27.96%
Holding
739
New
70
Increased
160
Reduced
252
Closed
106

Top Sells

Rank Stock Value
1
THD icon
iShares MSCI Thailand ETF
THD
+$7.93M
2
ECH icon
iShares MSCI Chile ETF
ECH
+$6.49M
3
BA icon
Boeing
BA
+$6.44M
4
LIN icon
Linde
LIN
+$6.16M
5
CC icon
Chemours
CC
+$4.87M

Sector Composition

Rank Sector Weight
1 Materials 9.77%
2 Energy 7.83%
3 Technology 7.77%
4 Financials 7.67%
5 Consumer Discretionary 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
251
Monster Beverage
MNST
$91.4B
$156K 0.03%
5,706
-642
-10% -$18.3K
KGC icon
252
Kinross Gold
KGC
$28.5B
$154K 0.03%
+44,883
New +$150K
NSA
253
DELISTED
National Storage Affiliates Trust
NSA
$154K 0.03%
+5,396
New +$150K
MO icon
254
Altria Group
MO
$122B
$153K 0.03%
2,673
-19,546
-88% -$999K
D icon
255
Dominion Energy
D
$62.5B
$153K 0.03%
1,990
+850
+75% +$62.1K
AMTD
256
DELISTED
TD Ameritrade Holding Corp
AMTD
$152K 0.03%
3,046
-704
-19% -$38.1K
PK icon
257
Park Hotels & Resorts
PK
$2.97B
$149K 0.03%
+4,800
New +$144K
WYNN icon
258
Wynn Resorts
WYNN
$10.1B
$149K 0.03%
1,250
-12,936
-91% -$1.55M
TEVA icon
259
Teva Pharmaceuticals
TEVA
$35.9B
$146K 0.03%
+9,311
New +$164K
CMA
260
DELISTED
Comerica
CMA
$145K 0.03%
1,979
-430
-18% -$34.5K
AUB icon
261
Atlantic Union Bankshares
AUB
$5.99B
$145K 0.03%
4,477
-590
-12% -$19.7K
ETFC
262
DELISTED
E*Trade Financial Corporation
ETFC
$135K 0.03%
2,906
-687
-19% -$32.7K
TBBK icon
263
The Bancorp
TBBK
$2.79B
$134K 0.03%
16,597
-2,195
-12% -$19K
TVRD
264
Tvardi Therapeutics
TVRD
$23.5M
$133K 0.03%
189
-11
-6% -$6.58K
WTFC icon
265
Wintrust Financial
WTFC
$10.7B
$132K 0.03%
1,954
-418
-18% -$29.9K
SIVB
266
DELISTED
SVB Financial Group
SIVB
$131K 0.03%
591
-147
-20% -$34.2K
CWB icon
267
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
$127K 0.03%
2,435
+161
+7% +$8.17K
VWOB icon
268
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$126K 0.03%
1,614
+107
+7% +$8.22K
FDC
269
DELISTED
First Data Corporation
FDC
$123K 0.02%
4,700
FNSR
270
DELISTED
Finisar Corp
FNSR
$123K 0.02%
5,300
-20,233
-79% -$462K
EQR icon
271
Equity Residential
EQR
$25.4B
$122K 0.02%
1,617
-2,633
-62% -$190K
BBAR icon
272
BBVA Argentina
BBAR
$3.85B
$121K 0.02%
12,770
+9,749
+323% +$116K
TAP icon
273
Molson Coors Class B
TAP
$7.68B
$121K 0.02%
2,024
+551
+37% +$34K
FOLD
274
DELISTED
Amicus Therapeutics
FOLD
$120K 0.02%
8,800
EAF icon
275
GrafTech
EAF
$194M
$119K 0.02%
934
-162
-15% -$21.5K

Similar funds

Exane Derivatives's Q1 2019 Portfolio in Review

As of Q1 2019, Exane Derivatives held 739 positions worth $506M, down 9.2% from $557M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Exane Derivatives withdrew a net $43.2M in Q1 2019, closing 106 positions and reducing 252 holdings. Its most notable exit was Boeing, an estimated $6.44M position sold in full.

By sector, the portfolio is most concentrated in Materials at 9.8% of assets, down from 11% a quarter earlier, followed by Energy and Technology.

Against the trend, Exane Derivatives opened a new position in UBS Group worth $11.2M.

  • Exane Derivatives's largest Q1 2019 buy was UBS Group: 919,334 shares worth $11.2M.
  • Exane Derivatives added most to iShares MSCI Philippines ETF in Q1 2019, an estimated $9.69M increase.
  • Exane Derivatives's biggest Q1 2019 reduction was iShares MSCI Thailand ETF, cutting an estimated $7.93M.
  • Exane Derivatives fully exited Boeing in Q1 2019, selling an estimated $6.44M.
  • Exane Derivatives's ten largest holdings make up 28% of its $506M portfolio in Q1 2019.
  • Exane Derivatives opened 70 new positions and closed 106 in Q1 2019.
  • Exane Derivatives's portfolio value fell 9.2% quarter-over-quarter to $506M.

Based on Exane Derivatives's 13F filing for Q1 2019, filed 24 Apr 2019.